Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India
Emerging infectious diseases,
Год журнала:
2023,
Номер
29(1), С. 8 - 19
Опубликована: Янв. 1, 2023
Abstract
We
performed
a
case–control
study
across
25
hospitals
in
India
for
the
period
of
January–June
2021
to
evaluate
reasons
an
COVID-19–associated
mucormycosis
(CAM)
outbreak.
investigated
whether
COVID-19
treatment
practices
(glucocorticoids,
zinc,
tocilizumab,
and
others)
were
associated
with
CAM.
included
1,733
cases
CAM
3,911
age-matched
controls.
found
cumulative
glucocorticoid
dose
(odds
ratio
[OR]
1.006,
95%
CI
1.004–1.007)
zinc
supplementation
(OR
2.76,
2.24–3.40),
along
elevated
C-reactive
protein
1.004,
1.002–1.006),
host
factors
(renal
transplantation
[OR
7.58,
3.31–17.40],
diabetes
mellitus
6.72,
5.45–8.28],
diabetic
ketoacidosis
during
4.41,
2.03–9.60]),
rural
residence
2.88,
2.12–3.79),
significantly
Mortality
rate
at
12
weeks
was
32.2%
(473/1,471).
emphasize
judicious
use
therapies
optimal
glycemic
control
prevent
Язык: Английский
The changing epidemiology of fungal infections
Molecular Aspects of Medicine,
Год журнала:
2023,
Номер
94, С. 101215 - 101215
Опубликована: Окт. 5, 2023
Invasive
fungal
diseases
are
common
complications
in
critically
ill
patients
and
those
with
significant
underlying
imbalanced
immune
systems.
Fungal
co-,
and/or
super-infections
emerging
have
become
a
rising
concern
within
the
last
few
years.
In
Europe,
cases
of
candidiasis
aspergillosis
dominate,
followed
by
mucormycosis
India.
Epidemiological
studies
show
an
increasing
trend
incidence
all
three
entities.
Parallel
to
this,
shift
pathogens
is
observed.
More
non-albicans
Candida
infections
cryptic
species
on
rise;
may
cover
intrinsic
resistance
azoles
other
antifungal
drugs.
The
recent
COVID-19
pandemic
led
significantly
invasive
among
hospitalized
patients.
Язык: Английский
COVID-19-Associated Pulmonary Mucormycosis
Journal of Fungi,
Год журнала:
2022,
Номер
8(7), С. 711 - 711
Опубликована: Июль 5, 2022
COVID-19-associated
mucormycosis
(CAM)
emerged
as
an
epidemic
in
certain
parts
of
the
world
amidst
global
COVID-19
pandemic.
While
rhino-orbital
was
well
reported
during
pandemic,
absence
routine
diagnostic
facilities
including
lower
airway
sampling,
pulmonary
probably
under-recognized.
In
this
review,
we
have
focused
on
epidemiology
and
management
(CAPM).
CAPM
is
a
deadly
disease
mortality
can
be
high
80%
early
clinical
suspicion
treatment.
histopathological
examination
tissue
for
angio-invasion
cultures
remained
gold
standard
diagnosis,
there
increasing
interest
molecular
serological
methods
to
facilitate
diagnosis
critically
ill
patients
often,
immune-suppressed
hosts
who
cannot
readily
undergo
invasive
sampling.
Combined
medical
surgical
treatment
offers
more
promise
than
standalone
therapy.
Maintaining
adequate
glycemic
control
prudent
use
steroids
which
double-edged
sword
are
key
preventative
measures.
We
would
like
emphasize
urgent
need
development
validation
reliable
biomarkers
diagnostics
diagnosis.
Язык: Английский